Sidna M. Tulledge‐Scheitel

Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial

Víctor M. Montori, Nilay D. Shah, Laurie J. Pencille et al. · The American Journal of Medicine · 2011 · 196 citations

Medical Decision Making, Preventive Medicine, Health Policy +12

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

Raymund R. Razonable, Colin Pawlowski, John C. O’Horo et al. · EClinicalMedicine · 2021 · 134 citations · Full text

Impact of Patient Portal Secure Messages and Electronic Visits on Adult Primary Care Office Visits

Frederick North, Sarah J. Crane, Rajeev Chaudhry et al. · Telemedicine Journal and e-Health · 2013 · 106 citations · Full text

Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

Ravindra Ganesh, Lindsey M. Philpot, Dennis M. Bierle et al. · The Journal of Infectious Diseases · 2021 · 102 citations · Full text

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons

Nischal Ranganath, John C. O’Horo, Douglas W. Challener et al. · Clinical Infectious Diseases · 2022 · 80 citations · Full text

Rebound Phenomenon, Additional Covid-19-directed Therapy, Viral Persistence +15